NDC 72893-002

Beleodaq

Belinostat

Beleodaq is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Acrotech Biopharma Llc. The primary component is Belinostat.

Product ID72893-002_0d662a88-5ace-48ff-9545-f3abff28d2a9
NDC72893-002
Product TypeHuman Prescription Drug
Proprietary NameBeleodaq
Generic NameBelinostat
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2014-07-21
Marketing CategoryNDA / NDA
Application NumberNDA206256
Labeler NameAcrotech Biopharma LLC
Substance NameBELINOSTAT
Active Ingredient Strength500 mg/10mL
Pharm ClassesHistone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 72893-002-01

1 VIAL in 1 CARTON (72893-002-01) > 10 mL in 1 VIAL
Marketing Start Date2014-07-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72893-002-01 [72893000201]

Beleodaq INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA206256
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-07-21

Drug Details

Active Ingredients

IngredientStrength
BELINOSTAT500 mg/10mL

OpenFDA Data

SPL SET ID:2e8ef36b-71fa-4492-a16f-577d5f7d111d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1543552
  • 1543547
  • Pharmacological Class

    • Histone Deacetylase Inhibitor [EPC]
    • Histone Deacetylase Inhibitors [MoA]

    NDC Crossover Matching brand name "Beleodaq" or generic name "Belinostat"

    NDCBrand NameGeneric Name
    68152-108BeleodaqBelinostat
    69605-002BeleodaqBelinostat
    72893-002BeleodaqBelinostat

    Trademark Results [Beleodaq]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    BELEODAQ
    BELEODAQ
    86140026 4626277 Live/Registered
    ACROTECH BIOPHARMA LLC
    2013-12-10

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.